Content by The Scripps Research Institute
Researchers uncover proteins that halt cancer cell growth when targeted by certain compounds
| 4 min read
Combining the drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective cancer therapy
| 4 min read
Researchers develop a drug-like molecule that blocks the first stage of influenza A
| 3 min read
Team uncovers a cost-effective method for producing quaternary carbon molecules, which are critical for drug development
| 2 min read
New, high-resolution technique for finding potential therapeutic targets on proteins in living cells
| 2 min read
New findings suggest that treating insomnia can stop opioid-seeking behavior, even after ending treatment
| 2 min read
By revealing how the structure of the PI3Kα protein changes in cancer cells, scientists point toward ways to target it
| 2 min read
Finding uncovers a key property needed for CELMoD drugs, a type of protein degrader, to work effectively
| 3 min read
“Pytheas” app allows scientists to identify and quantify modified RNA molecules more easily than ever
| 2 min read
A new antibody discovered in the blood of some people vaccinated against or infected with influenza can recognize a broad variety of flu viruses
| 3 min read
Advance provides new tools for synthetic chemists and biologists looking to probe and modify sulfur-based biochemistry
| 3 min read
Newly described chemical reaction could have assembled DNA building blocks before life forms and their enzymes existed
| 3 min read
Researchers harness information theory to better understand how to make complex and compact molecules resembling those in nature
| 3 min read
Scripps Research collaborators develop a way to seamlessly create the compound's complex structure
| 3 min read
Analysis of data from 16 groups of COVID-19 patients suggest 'silent' carriers may exacerbate efforts to stop spread of the disease
| 2 min read
Page 1 of 8 - 114 Total Items
